文献

J-GLOBAL ID：201402241643633271   整理番号：14A0801241

重症下肢虚血の血管内治療後の予後に対するサルポグレラート治療の効果

Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia

著者 (6件)： TAKAHARA Mitsuyoshi (Osaka Univ. Graduate School of Medicine, Dep. of Metabolic Medicine, 2-2 Yamadaoka, 565-0871, Suita, Osaka, JPN) ,  KANETO Hideaki (Osaka Univ. Graduate School of Medicine, Dep. of Metabolic Medicine, 2-2 Yamadaoka, 565-0871, Suita, Osaka, JPN) ,  KATAKAMI Naoto (Osaka Univ. Graduate School of Medicine, Dep. of Metabolic Medicine, 2-2 Yamadaoka, 565-0871, Suita, Osaka, JPN) ,  IIDA Osamu (Kansai Rosai Hospital, Dep. of Internal Medicine, Hyogo, JPN) ,  MATSUOKA Taka-Aki (Osaka Univ. Graduate School of Medicine, Dep. of Metabolic Medicine, 2-2 Yamadaoka, 565-0871, Suita, Osaka, JPN) ,  SHIMOMURA Iichiro (Osaka Univ. Graduate School of Medicine, Dep. of Metabolic Medicine, 2-2 Yamadaoka, 565-0871, Suita, Osaka, JPN)
資料名： Heart and Vessels  (Heart and Vessels)
巻： 29  号： 4  ページ： 563-567  発行年： 2014年07月 
JST資料番号： X0101A  ISSN： 0910-8327  資料種別： 逐次刊行物 (A)
記事区分： 短報  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 5-ヒドロキシトリプタミン2型拮抗薬は症候性末梢動脈疾患の治...

シソーラス用語： 血管作用薬 ,...
準シソーラス用語： *重症下肢虚血

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0801241&from=J-GLOBAL&jstjournalNo=X0101A") }}

分類 (2件)： 血管作用薬・降圧薬の臨床への応用  (GW07050U) ,  循環系疾患の薬物療法  (GJ05020M)

物質索引 (1件)： サルポグレラート

引用文献 (29件)：

• Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):S1-S75
• Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC (2010) Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg 52:843-49.e1
• Takahara M, Kaneto H, Iida O, Katakami N, Sakamoto F, Matsuoka TA, Ikeda M, Shimomura I (2011) No association of diabetic duration or insulin use with the prognosis of critical limb ischemia after endovascular therapy. J Atheroscler Thromb 18:1102-1109
• Regensteiner JG, Ware JE Jr, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR (2002) Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatr Soc 50:1939-1946
• Lehert P, Comte S, Gamand S, Brown TM (1994) Naftidrofuryl in intermittent claudication: a retrospective analysis. J Cardiovasc Pharmacol 23(Suppl 3):S48-S52

タイトルに関連する用語 (5件)： 重症下肢虚血 ,  血管内治療 ,  予後 ,  サルポグレラート ,  治療